Sort
35,931 grants matching “parkinsons”
The autophagy lysosomal pathway: regulation by progranulin and its role in neurodegenerative disease
$563,418Steven M Finkbeiner · Northwestern University · P01 · FY2021 · AG
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
$563,346Jing Wang · University Of Minnesota · R01 · FY2020 · NS
Brain anatomical correlates of mobility control in the oldest old
$563,327Caterina Rosano · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AG
Microconnectomics of neocortex: a multiscale computer model
$563,317William W Lytton · Suny Downstate Medical Center · U01 · FY2016 · EB
Regulation of Neurodegeneration by Nonpathogenic Cellular Prion Protein and LRP1
$563,313Steven L. Gonias · University Of California, San Diego · R01 · FY2025 · NS
Regulation of Neurodegeneration by Nonpathogenic Cellular Prion Protein and LRP1
$563,313Steven L. Gonias · University Of California, San Diego · R01 · FY2024 · NS
Neuroprotective role of GLP-1 receptor agonists
$563,293Nigel H. Greig · National Institute On Aging · ZIA · FY2018 · AG
Neuroprotective Immunity and HIV Dementia
$563,091Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2021 · NS
Neuroprotective Immunity and HIV Dementia
$563,091Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2022 · NS
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
$563,087Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2022 · MH
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
$563,087Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2021 · MH
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
$563,087Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2023 · MH
Metabolomics and risk of Parkinson's Disease
$563,079Alberto Ascherio · Harvard School Of Public Health · R01 · FY2017 · NS
Metabolomics and risk of Parkinson's Disease
$563,079Alberto Ascherio · Harvard School Of Public Health · R01 · FY2018 · NS
Metabolomics and risk of Parkinson's Disease
$563,079Alberto Ascherio · Harvard School Of Public Health · R01 · FY2016 · NS
Physiology and Genetics of GDNF Family of Ligands (GFLS)
$563,052Jeffrey D Milbrandt · Washington University · R01 · FY2009 · AG
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$563,038Rima F Kaddurah-Daouk · Duke University · U19 · FY2020 · AG
MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)
$563,025Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2020 · DA
DJ-1 and hexokinases
$562,984Mark Cookson · National Institute On Aging · ZIA · FY2019 · AG
Mesenchymal Stem Cell Derived A-1 Exosomes for Traumatic Brain Injury
$562,924Ashok K. Shetty · Texas A&M University Health Science Ctr · R01 · FY2022 · NS
FXTAS: Mechanisms and Modifiers
$562,869David Loren Nelson · Baylor College Of Medicine · P50 · FY2020 · HD
Phase 1b Trial of stem cells in ALS
$562,841Jonathan David Glass · Emory University · R01 · FY2013 · NS
Project 2: 3-D Molecular atlas of AD proteinopathy
$562,819Vilas Menon · Columbia University Health Sciences · U19 · FY2023 · AG
The autophagy lysosomal pathway: regulation by progranulin and its role in neurodegenerative disease
$562,785Steven M Finkbeiner · Northwestern University · P01 · FY2022 · AG
Dopamine-induced PET occupancy explored by PET/fMRI
$562,706Joseph B Mandeville · Massachusetts General Hospital · R01 · FY2021 · NS